NKG2D‐mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes
Authors:
- 11 August 2009
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 146 (5) , 538-545
Abstract
It is considered that a similar immune mechanism acts in the pathogenesis of bone marrow (BM) failure in paroxysmal nocturnal haemoglobinuria (PNH) and its related disorders, such as aplastic anaemia (AA) and myelodysplastic syndromes (MDS). However, the molecular events in immune-mediated marrow injury have not been elucidated. We recently reported an abnormal expression of stress-inducible NKG2D (natural-killer group 2, member D) ligands, such as ULBP (UL16-binding protein) and MICA/B (major histocompatibility complex class I chain-related molecules A/B), on granulocytes in some PNH patients and the granulocyte killing by autologous lymphocytes in vitro. The present study found that the expression of NKG2D ligands was common to both granulocytes and BM cells of patients with PNH, AA, and MDS, indicating their exposure to some incitement to induce the ligands. The haematopoietic colony formation in vitro by the patients' marrow cells significantly improved when their BM cells were pretreated with antibodies against NKG2D receptor, suggesting that the antibodies rescued haematopoietic cells expressing NKG2D ligands from damage by autologous lymphocytes with NKG2D. Clinical courses of patients with PNH and AA showed a close association of the expression of NKG2D ligands with BM failure and a favourable response to immunosuppressive therapy. We therefore propose that NKG2D-mediated immunity may underlie the BM failure in PNH and its-related marrow diseases.Keywords
This publication has 28 references indexed in Scilit:
- Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virusProceedings of the National Academy of Sciences, 2007
- Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemiaBlood, 2006
- Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBPBlood, 2006
- Diagnosis and management of paroxysmal nocturnal hemoglobinuriaBlood, 2005
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural KillingImmunity, 2002
- Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by Vβ CDR3 spectratyping and flow cytometryBlood, 2002
- ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cellsEuropean Journal of Immunology, 2001
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982